Bruker (BRKR) Competitors

Agilent Technologies has a net margin of 18.26% compared to Bruker's net margin of -0.25%. Agilent Technologies' return on equity of 24.49% beat Bruker's return on equity.

Agilent Technologies has higher revenue and earnings than Bruker. Bruker is trading at a lower price-to-earnings ratio than Agilent Technologies, indicating that it is currently the more affordable of the two stocks.

Agilent Technologies pays an annual dividend of $1.02 per share and has a dividend yield of 0.9%. Bruker pays an annual dividend of $0.20 per share and has a dividend yield of 0.5%. Agilent Technologies pays out 22.5% of its earnings in the form of a dividend. Bruker pays out -133.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Agilent Technologies has increased its dividend for 9 consecutive years. Agilent Technologies is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Agilent Technologies has a beta of 1.22, meaning that its stock price is 22% more volatile than the S&P 500. Comparatively, Bruker has a beta of 1.12, meaning that its stock price is 12% more volatile than the S&P 500.

79.5% of Bruker shares are owned by institutional investors. 27.2% of Bruker shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Agilent Technologies currently has a consensus target price of $163.71, suggesting a potential upside of 39.27%. Bruker has a consensus target price of $49.38, suggesting a potential upside of 29.93%. Given Agilent Technologies' stronger consensus rating and higher possible upside, equities analysts plainly believe Agilent Technologies is more favorable than Bruker.

In the previous week, Agilent Technologies had 5 more articles in the media than Bruker. MarketBeat recorded 11 mentions for Agilent Technologies and 6 mentions for Bruker. Agilent Technologies' average media sentiment score of 0.97 beat Bruker's score of 0.48 indicating that Agilent Technologies is being referred to more favorably in the media.

Bio-Rad Laboratories has a net margin of 6.52% compared to Bruker's net margin of -0.25%. Bruker's return on equity of 13.56% beat Bio-Rad Laboratories' return on equity.

Bio-Rad Laboratories has higher earnings, but lower revenue than Bruker. Bruker is trading at a lower price-to-earnings ratio than Bio-Rad Laboratories, indicating that it is currently the more affordable of the two stocks.

Bio-Rad Laboratories has a beta of 1.06, meaning that its stock price is 6% more volatile than the S&P 500. Comparatively, Bruker has a beta of 1.12, meaning that its stock price is 12% more volatile than the S&P 500.

65.2% of Bio-Rad Laboratories shares are owned by institutional investors. Comparatively, 79.5% of Bruker shares are owned by institutional investors. 30.3% of Bio-Rad Laboratories shares are owned by insiders. Comparatively, 27.2% of Bruker shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Bio-Rad Laboratories currently has a consensus target price of $333.00, suggesting a potential upside of 29.41%. Bruker has a consensus target price of $49.38, suggesting a potential upside of 29.93%. Given Bruker's stronger consensus rating and higher probable upside, analysts clearly believe Bruker is more favorable than Bio-Rad Laboratories.

In the previous week, Bio-Rad Laboratories had 11 more articles in the media than Bruker. MarketBeat recorded 17 mentions for Bio-Rad Laboratories and 6 mentions for Bruker. Bruker's average media sentiment score of 0.48 beat Bio-Rad Laboratories' score of -0.12 indicating that Bruker is being referred to more favorably in the news media.

79.1% of Danaher shares are owned by institutional investors. Comparatively, 79.5% of Bruker shares are owned by institutional investors. 10.8% of Danaher shares are owned by company insiders. Comparatively, 27.2% of Bruker shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Danaher has a beta of 0.81, meaning that its share price is 19% less volatile than the S&P 500. Comparatively, Bruker has a beta of 1.12, meaning that its share price is 12% more volatile than the S&P 500.

In the previous week, Danaher had 24 more articles in the media than Bruker. MarketBeat recorded 30 mentions for Danaher and 6 mentions for Bruker. Danaher's average media sentiment score of 1.07 beat Bruker's score of 0.48 indicating that Danaher is being referred to more favorably in the media.

Danaher pays an annual dividend of $1.60 per share and has a dividend yield of 0.9%. Bruker pays an annual dividend of $0.20 per share and has a dividend yield of 0.5%. Danaher pays out 30.9% of its earnings in the form of a dividend. Bruker pays out -133.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Danaher has increased its dividend for 2 consecutive years. Danaher is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Danaher currently has a consensus target price of $240.70, suggesting a potential upside of 37.79%. Bruker has a consensus target price of $49.38, suggesting a potential upside of 29.93%. Given Danaher's stronger consensus rating and higher probable upside, equities research analysts clearly believe Danaher is more favorable than Bruker.

Danaher has higher revenue and earnings than Bruker. Bruker is trading at a lower price-to-earnings ratio than Danaher, indicating that it is currently the more affordable of the two stocks.

Danaher has a net margin of 14.89% compared to Bruker's net margin of -0.25%. Bruker's return on equity of 13.56% beat Danaher's return on equity.

In the previous week, IQVIA had 13 more articles in the media than Bruker. MarketBeat recorded 19 mentions for IQVIA and 6 mentions for Bruker. IQVIA's average media sentiment score of 0.68 beat Bruker's score of 0.48 indicating that IQVIA is being referred to more favorably in the news media.

Bruker presently has a consensus target price of $49.38, suggesting a potential upside of 29.93%. IQVIA has a consensus target price of $226.63, suggesting a potential upside of 28.55%. Given Bruker's higher probable upside, equities analysts clearly believe Bruker is more favorable than IQVIA.

IQVIA has a net margin of 8.34% compared to Bruker's net margin of -0.25%. IQVIA's return on equity of 30.50% beat Bruker's return on equity.

IQVIA has higher revenue and earnings than Bruker. Bruker is trading at a lower price-to-earnings ratio than IQVIA, indicating that it is currently the more affordable of the two stocks.

79.5% of Bruker shares are held by institutional investors. Comparatively, 89.6% of IQVIA shares are held by institutional investors. 27.2% of Bruker shares are held by company insiders. Comparatively, 1.7% of IQVIA shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Bruker has a beta of 1.12, suggesting that its share price is 12% more volatile than the S&P 500. Comparatively, IQVIA has a beta of 1.18, suggesting that its share price is 18% more volatile than the S&P 500.